Bloomberg Amgen Inc.’s new cholesterol drug is still struggling to gain traction, missing analysts’ estimates at a time when the biotechnology giant is anxious for its newer drugs to make up for slowing sales of its older ones. Sales of the drug, called Repatha, in the first quarter were $49 million, the company said in a statement. That was ...

  Bloomberg Britain’s largest business lobby said the UK and the rest of the European Union need to settle any exit bill fast and get cracking on a new trade deal. Confederation of British Industry Director General Carolyn Fairbairn said a good Brexit arrangement isn’t about “doing the UK a favor,” but based on “solid economic reasoning for both sides.” ...

  The French are too intellectually vain to borrow others’ political ideas, but too interested in style not to appreciate and appropriate that of others. So, on May 7 they might confer their presidency on a Gallic Barack Obama. In 2008, Obama, a freshman senator, became a national Rorschach test, upon whom Americans projected their longings. Emmanuel Macron, 39, is ...